ARV/ART

eLearning course
August 27, 2020

 

The National Department of Health is introducing a new drug, Dolutegravir (DTG), in combination with Tenofovir (TDF) and Lamivudine (3TC). The combination of TDF/3TC/DTG is known as TLD. The objectives of this training are to:

eLearning course
August 27, 2020

 

The National Department of Health is introducing a new drug, Dolutegravir (DTG), in combination with Tenofovir (TDF) and Lamivudine (3TC). The combination of TDF/3TC/DTG is known as TLD. The objectives of this training are to:

Resource
July 6, 2020

Introduction

Few studies have systematically described population‐level differences comparing men and women across the continuum of routine HIV care.

News
June 25, 2020

UNAIDS study shows that the impact on production and logistics caused by COVID-19 could have a significant effect on antiretroviral therapy supply worldwide, but steps taken now could lessen the damage done

Resource
June 18, 2020

Introduction

South Africa introduced Universal Test and Treat in 2016 including antiretroviral therapy (ART) initiation on the same‐day as HIV diagnosis.

Resource
June 17, 2020

Darunavir/ritonavir administered with rifampicin causes hepatotoxicities in people living with HIV, according to results of a study led by researchers at the department of medicine, the Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa) and the Desm